Meeting
2018 ASCO Annual Meeting
The role of adiposity in the association between type 2 diabetes and the risk of breast cancer.
Authors
Maria Bota
University of Strathclyde Institute for Global Public Health at iPRI, Ecully, France
Maria Bota , Philippe Autier , Peter Boyle
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Hereditary Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Etiology/Epidemiology
Citation
J Clin Oncol 36, 2018 (suppl; abstr 1573)
DOI
10.1200/JCO.2018.36.15_suppl.1573
Abstract #
1573
Poster Bd #
144
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Chemoprotective effect of metformin against HR+/HER2- breast cancer among women with type-2 diabetes.
First Author: Soumya Chikermane
Poster
2021 ASCO Annual Meeting
Bone safety profile of steroidal aromatase inhibitor in comparison to non-steroidal aromatase inhibitors in postmenopausal women with breast cancer: A network meta-analysis.
First Author: Shanshan Chen
Poster
2018 ASCO Annual Meeting
Pretreatment physical activity to predict short- and long-term chemotherapy-induced peripheral neuropathy (CIPN) in a nationwide longitudinal study of paclitaxel for breast cancer.
First Author: Ian Kleckner
Poster
2017 ASCO Annual Meeting
Toxicity of extended adjuvant aromatase inhibitors therapy in postmenopausal breast cancer patients: A systematic review and meta-analysis.
First Author: Hadar Goldvaser